For help on how to get the results you want, see our search tips.
1483 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Galafold (updated)
migalastat hydrochloride, Fabry Disease
Date of authorisation: 25/05/2016,
, 
, Revision: 12, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): Sivextro (updated)
tedizolid phosphate, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 23/03/2015, Revision: 16, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Fabrazyme (updated)
agalsidase beta, Fabry Disease
Date of authorisation: 03/08/2001, Revision: 30, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Lixiana (updated)
edoxaban tosilate, Stroke, Venous Thromboembolism
Date of authorisation: 19/06/2015, Revision: 14, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Zejula (updated)
Niraparib (tosilate monohydrate), Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms
Date of authorisation: 16/11/2017,, , Revision: 12, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): Mavenclad (updated)
Cladribine, Multiple Sclerosis
Date of authorisation: 22/08/2017, Revision: 4, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka) (updated)
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,
, 
, Revision: 13, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Janssen (updated)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, 
, Revision: 1, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): Obizur (updated)
susoctocog alfa, Hemophilia A
Date of authorisation: 11/11/2015,, 
, Revision: 7, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): Neoclarityn (updated)
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 40, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Natpar (updated)
parathyroid hormone, Hypoparathyroidism
Date of authorisation: 24/04/2017,, , , Revision: 9, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): Xyrem (updated)
sodium oxybate, Cataplexy, Narcolepsy
Date of authorisation: 13/10/2005, Revision: 31, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Ganfort (updated)
bimatoprost, timolol, Glaucoma, Open-Angle, Ocular Hypertension
Date of authorisation: 19/05/2006, Revision: 20, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) (updated)
reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain, Influenza, Human
Date of authorisation: 20/05/2016,, , Revision: 7, Authorised, Last updated: 23/04/2021
-
List item
Human medicine European public assessment report (EPAR): Fasenra (updated)
benralizumab, Asthma
Date of authorisation: 08/01/2018,, Revision: 6, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d. (updated)
emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 28/04/2017,, Revision: 8, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Genvoya (updated)
elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 19/11/2015, Revision: 22, Authorised, Last updated: 22/04/2021 -
List item
Human medicine European public assessment report (EPAR): Akynzeo (updated)
netupitant, palonosetron hydrochloride, Vomiting, Cancer, Nausea
Date of authorisation: 27/05/2015, Revision: 9, Authorised, Last updated: 22/04/2021 -
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,, 
, Revision: 14, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva (updated)
emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 09/11/2016,, Revision: 5, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Ontruzant (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 15/11/2017,, 
, Revision: 9, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Movymia (updated)
teriparatide, Osteoporosis
Date of authorisation: 11/01/2017,, , Revision: 8, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Isentress (updated)
Raltegravir, HIV Infections
Date of authorisation: 19/12/2007,, Revision: 38, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Cinryze (updated)
C1 inhibitor (human), Angioedemas, Hereditary
Date of authorisation: 15/06/2011,, Revision: 20, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Benepali (updated)
etanercept, Arthritis, Psoriatic, Arthritis, Rheumatoid, Psoriasis
Date of authorisation: 13/01/2016,, Revision: 14, Authorised, Last updated: 22/04/2021